Company Intelligence
HistoWiz
HistoWiz provides enterprise-grade artificial intelligence solutions, delivering specialized Accelerating Histopathology for Cancer Research technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.
- Headquarters
- New York City, United States
- Website
- histowiz.com
- Founded
- 2016
- Employees
- 2
- Stage
- Growth
- Status
- Active
- Products
- 1
- Reports
- 8
- Last reviewed
- Aug 2026
Overview
What this company is, what it builds, and who it serves.
HistoWiz is a Healthcare AI company based in New York City, United States, founded in 2016.
HistoWiz develops accelerating Histopathology for Cancer Research.
What it builds
Accelerating Histopathology for Cancer Research
Why It Matters
HistoWiz provides enterprise-grade artificial intelligence solutions, delivering specialized Accelerating Histopathology for Cancer Research technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.
Products
Products and platforms connected to this company.
-
HistoWiz
Explore HistoWiz by HistoWiz. Verified AI product intelligence covering core capabilities, Healthcare use cases, technical architecture, and FAQs.
View product intelligence
Ecosystem
How this company connects across the Brel AI intelligence graph.
Company
HistoWiz
Industry
Products
Capabilities
- Accelerating Histopathology for Cancer Research
Features
- Accelerating Histopathology for Cancer Research
Country
Official Resources
Official and developer links on file for this company.
Frequently Asked Questions
What does HistoWiz do?
HistoWiz specializes in artificial intelligence, developing Accelerating Histopathology for Cancer Research to support enterprise software developers and digital transformation teams with scalable, production-grade technology.
Where is HistoWiz based and when was it founded?
HistoWiz is based in United States and was founded in 2016.
What are the main products offered by HistoWiz?
The flagship platform from HistoWiz is Accelerating Histopathology for Cancer Research, delivered primarily through b2b saas and enterprise api licensing.
Who are the primary target users of HistoWiz?
HistoWiz primarily serves enterprise software developers and digital transformation teams seeking reliable artificial intelligence implementations.
Sources & Verification
How this profile is verified and where the information comes from.
Primary sources
Request a correction if you represent this company or believe information is inaccurate.